SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis

Detalles Bibliográficos
Autores principales: Tuncay, Gülseren, Bostan, Ozge Can, Damadoglu, Ebru, Karakaya, Gül, Kalyoncu, Ali Fuat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894735/
https://www.ncbi.nlm.nih.gov/pubmed/35257871
http://dx.doi.org/10.1016/j.anai.2022.02.026
_version_ 1784662750441504768
author Tuncay, Gülseren
Bostan, Ozge Can
Damadoglu, Ebru
Karakaya, Gül
Kalyoncu, Ali Fuat
author_facet Tuncay, Gülseren
Bostan, Ozge Can
Damadoglu, Ebru
Karakaya, Gül
Kalyoncu, Ali Fuat
author_sort Tuncay, Gülseren
collection PubMed
description
format Online
Article
Text
id pubmed-8894735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88947352022-03-04 SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis Tuncay, Gülseren Bostan, Ozge Can Damadoglu, Ebru Karakaya, Gül Kalyoncu, Ali Fuat Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-06 2022-03-04 /pmc/articles/PMC8894735/ /pubmed/35257871 http://dx.doi.org/10.1016/j.anai.2022.02.026 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Tuncay, Gülseren
Bostan, Ozge Can
Damadoglu, Ebru
Karakaya, Gül
Kalyoncu, Ali Fuat
SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
title SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
title_full SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
title_fullStr SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
title_full_unstemmed SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
title_short SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
title_sort sars-cov-2 vaccines are well tolerated in patients with mastocytosis
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894735/
https://www.ncbi.nlm.nih.gov/pubmed/35257871
http://dx.doi.org/10.1016/j.anai.2022.02.026
work_keys_str_mv AT tuncaygulseren sarscov2vaccinesarewelltoleratedinpatientswithmastocytosis
AT bostanozgecan sarscov2vaccinesarewelltoleratedinpatientswithmastocytosis
AT damadogluebru sarscov2vaccinesarewelltoleratedinpatientswithmastocytosis
AT karakayagul sarscov2vaccinesarewelltoleratedinpatientswithmastocytosis
AT kalyoncualifuat sarscov2vaccinesarewelltoleratedinpatientswithmastocytosis

Ejemplares similares